CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual diseaseWenyi Lu, Mingfeng Zhao, Xin Li et al.|Cancer Immunology Immunotherapy|2021Cited by 22
<p>Case Report of Anti-CD123 Chimeric Antigen Receptor T-Cell Therapy Followed by Radiotherapy for a Recurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem Cell Transplantation</p>Yili Jiang, Qi Deng, Qing Li et al.|OncoTargets and Therapy|2020Cited by 11
CD19 CAR-T Cells Treatment Conferred a Sustained Remission in Patients with Chemotherapy-Refractory MRD in B-ALLWenyi Lu, Mingfeng Zhao, Yunxiong Wei et al.|Blood|2020Cited by 0
[Overexpression of NKG2D-CD3ζ in NY-ESO-1 TCR-T cells enhanced cytotoxicity to acute myeloid leukemia cells <i>in vitro</i>].R Zhang, Qi Deng, Nan Mou et al.|PubMed|2020Cited by 0